PubMed 26156092
Referenced in: none
Automatically associated channels: TRP , TRPC , TRPC6
Title: Focal segmental glomerulosclerosis: molecular genetics and targeted therapies.
Authors: Ying Maggie Chen, Helen Liapis
Journal, date & volume: BMC Nephrol, 2015 , 16, 101
PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/26156092
Abstract
Recent advances show that human focal segmental glomerulosclerosis (FSGS) is a primary podocytopathy caused by podocyte-specific gene mutations including NPHS1, NPHS2, WT-1, LAMB2, CD2AP, TRPC6, ACTN4 and INF2. This review focuses on genes discovered in the investigation of complex FSGS pathomechanisms that may have implications for the current FSGS classification scheme. It also recounts recent recommendations for clinical management of FSGS based on translational studies and clinical trials. The advent of next-generation sequencing promises to provide nephrologists with rapid and novel approaches for the diagnosis and treatment of FSGS. A stratified and targeted approach based on the underlying molecular defects is evolving.